CISPLATIN, METHOTREXATE, AND 5-FLUOROURACIL COMBINATION CHEMOTHERAPY FOR ADVANCED OVARIAN-CANCER

被引:30
作者
CONTE, PF
SERTOLI, MR
BRUZZONE, M
RUBAGOTTI, A
ROSSO, R
BENTIVOGLIO, G
CONIO, A
PESCETTO, G
机构
[1] UNIV GENOA,IST NAZL RIC CANC,DIV ONCOL MED 1,I-16126 GENOA,ITALY
[2] UNIV GENOA,OSTET & GINECOL CLIN,I-16126 GENOA,ITALY
关键词
D O I
10.1016/0090-8258(85)90210-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:290 / 297
页数:8
相关论文
共 15 条
[1]  
AURE JC, 1977, OBSTET GYNECOL, V37, P1
[2]  
BARKER GH, 1981, LANCET, V1, P747
[3]   IMPROVED THERAPY WITH CISPLATIN REGIMENS FOR PATIENTS WITH OVARIAN-CARCINOMA (FIGO STAGE-III AND STAGE-IV) AS MEASURED BY SURGICAL END-STAGING (2ND-LOOK OPERATION) [J].
COHEN, CJ ;
GOLDBERG, JD ;
HOLLAND, JF ;
BRUCKNER, HW ;
DEPPE, G ;
GUSBERG, SB ;
WALLACH, RC ;
KABAKOW, B ;
RODIN, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1983, 145 (08) :955-967
[4]   A PROSPECTIVE RANDOMIZED CLINICAL-TRIAL OF MELPHALAN AND CIS-PLATINUM VERSUS HEXAMETHYLMELAMINE, ADRIAMYCIN, AND CYCLOPHOSPHAMIDE IN ADVANCED OVARIAN-CANCER [J].
EDWARDS, CL ;
HERSON, J ;
GERSHENSON, DM ;
COPELAND, LJ ;
WHARTON, JT .
GYNECOLOGIC ONCOLOGY, 1983, 15 (02) :261-277
[5]  
EHRLICH CE, 1979, CANCER TREAT REP, V63, P281
[6]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[7]   TOXICITY AND RESPONSE CRITERIA OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP [J].
OKEN, MM ;
CREECH, RH ;
TORMEY, DC ;
HORTON, J ;
DAVIS, TE ;
MCFADDEN, ET ;
CARBONE, PP .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (06) :649-655
[8]   DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .2. ANALYSIS AND EXAMPLES [J].
PETO, R ;
PIKE, MC ;
ARMITAGE, P ;
BRESLOW, NE ;
COX, DR ;
HOWARD, SV ;
MANTEL, N ;
MCPHERSON, K ;
PETO, J ;
SMITH, PG .
BRITISH JOURNAL OF CANCER, 1977, 35 (01) :1-39
[9]  
PETO R, 1976, BRIT J CANCER, V34, P385
[10]  
SILVERBERG E, 1981, CA-CANCER J CLIN, V31, P13